A role for the Rb family of proteins in controlling telomere length

Nature Genetics

Volumn 32, Issue 3, 2002, Pages 415-419

  García Cao, Marta ^a   Gonzalo, Susana ^b   Dean, Douglas ^b   Blasco, María A ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P107; PROTEIN P130; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING KINETICS; CELL DIVISION; CELL STRUCTURE; CHROMOSOMAL PARAMETERS; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOFLUORESCENCE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; TELOMERE;

ANIMALS; CELLS, CULTURED; CHROMOSOME ABERRATIONS; CHROMOSOMES; DNA; FIBROBLASTS; FLOW CYTOMETRY; GENOTYPE; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; NUCLEAR PROTEINS; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; TELOMERASE; TELOMERE;

ANIMALIA; MAMMALIA;

EID: 0036843088     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1011     Document Type: Article

References (29)

1. Blackburn, E.H. Switching and signaling at the telomere. Cell 106, 661-673 (2001).
2. Chan, S.W.-L. & Blackburn, E.H. New ways not to make ends meet: Telomerase, DNA damage proteins and heterochromatin. Oncogene 21, 553-563 (2002).
3. de Lange, T. Protection of mammalian telomeres. Oncogene 21, 532-540 (2002).
4. Goytisolo, F.A. & Blasco, M.A. Many ways to telomere dysfunction: In vivo studies using mouse models. Oncogene 21, 584-591 (2002).
5. Harley, C.B., Futcher, A.B. & Greider, C.W. Telomeres shorten during ageing of human fibroblasts. Nature 31, 459-460 (1990).
6. Collins, K. & Mitchell, J.R. Telomerase in the human organism. Oncogene 21, 564-579 (2002).
7. Blasco, M.A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34 (1997).
8. Lee, H.-W. et al. Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569-574 (1998).
9. -/- mice with short telomeres. EMBO Reports 2, 800-807 (2001).
10. Hemann, M.T., Strong, M.A., Hao, L.Y. & Greider, C.W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107, 67-77 (2001).
11. Bodnar, A.G. et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352 (1998).
12. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88 (1998).
13. Farwell, D.G. et al. Genetic and epigenetic changes in human epithelial cells immortalized by telomerase. Am. J. Pathol. 156, 1537-1547 (2000).
14. Stoppler, H., Hartmann, D.P., Sherman, L. & Schlegel, R. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length. J. Biol. Chem. 272, 13332-13337 (1997).
15. 1 control and immortalization. Genes Dev. 14, 3037-3050 (2000).
16. van Steensel, B., Smogorzewska, A. & de Lange, T. TRF2 protects human telomeres from end-to-end fusions. Cell 92, 401-413 (1998).
17. Samper, E., Goytisolo, F., Slijepcevic, P., van Buul, P. & Blasco, M.A. Mammalian Ku86 prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Reports 1, 244-252 (2000).
18. Goytisolo, F., Samper, E., Edmonson, S., Taccioli, G.E. & Blasco, M.A. Absence of DNA-PKcs in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang. Mol. Cell. Biol. 21, 3642-3651 (2001).
19. Hande, P.M., Samper, E., Lansdorp, P. & Blasco, M.A. Telomere length dynamics in cultured cells from normal and telomerase-null mice. J. Cell Biol. 144, 589-601 (1999).
20. Chong, L. et al. A human telomeric protein. Science 270, 1663-1667 (1995).
21. Smogorzewska, A. et al. Control of human telomere length by TRF1 and TRF2. Mol. Cell. Biol. 20, 1659-1668 (2000).
22. van Steensel, B. & de Lange, T. Control of telomere length by the human telomeric protein TRF1. Nature 385, 740-743 (1997).
23. Espejel, S. et al. Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J. 21, 2207-2219 (2002).
24. Henson, J.D., Neumann, A.A., Yeager, T.R. & Reddel, R.R. Alternative lengthening of telomeres in mammalian cells. Oncogene 21, 598-610 (2002).
25. Perrem, K., Colgin, L.M., Neumann, A.A., Yeager, T.R. & Reddel, R.R. Co-existence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol. Cell. Biol. 21, 3862-3875 (2001).
26. Murga, M. et al. Mutation of the E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity 15, 959-970 (2001).
27. McIlrath, J.S. et al. Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res. 61, 912-915 (2001).
28. Herrera, E. et al. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J. 18, 2950-2960 (1999).
29. Zijlmans, J.M. et al. Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats. Proc. Natl Acad. Sci. USA 94, 7423-7428 (1997).